Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity

This publication has 100 references indexed in Scilit:

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
  Published by Wiley ,2001
• Paradoxical action of the cannabinoid WIN 55,212‐2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices
  British Journal of Pharmacology, 1997
• Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligand
  Life Sciences, 1996
• Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function
  Brain Research, 1995
• Effect of dizocilpine (MK-801) on the catalepsy induced by ?9-tetrahydrocannabinol in mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids
  Neuropharmacology, 1991
• Behaviour in rats maintained by low differential reinforcement rate: Effects of Δ1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination
  Neuropharmacology, 1989
• Treatment of Human Spasticity with Δ⁹‐Tetrahydrocannabinol
  The Journal of Clinical Pharmacology, 1981
• Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
  Journal of the American Chemical Society, 1964